Goldman Sachs’s Replimune Group REPL Stock Holding History

Goldman Sachs’s Portfolio REPL Stock Details REPL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$111K	Buy	+10,000	New	+$61.2K	﹤0.01%	6322

Other funds holding REPL

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

RCI

Ridgeback Capital Investments Miami Beach, Florida $80.9M AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

FIS

FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Goldman Sachs's REPL Position: Q2 2026 in Review

Goldman Sachs increased its Replimune Group (REPL) stake by 99% in Q2 2026, buying an estimated $13.8M and bringing the position to 4,541,018 shares worth $50.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1800.

Goldman Sachs first reported a position in REPL in Q3 2018 and has held it in 32 quarters since. 199 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

Goldman Sachs held 4,541,018 shares of Replimune Group worth $50.3M as of Q2 2026.
Goldman Sachs bought 2,263,742 Replimune Group shares in Q2 2026, an estimated $13.8M.
Replimune Group made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #1800 holding.
Goldman Sachs first reported a position in Replimune Group in Q3 2018 and has held it in 32 quarters since.
199 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.